- Investing Ideas
- U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
17
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
17 companies
Madrigal Pharmaceuticals
Market Cap: US$10.1b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$454.22
7D
3.5%
1Y
35.5%
Ascendis Pharma
Market Cap: US$13.7b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.
ASND
US$223.82
7D
-1.0%
1Y
34.8%
Insmed
Market Cap: US$30.8b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$144.00
7D
3.2%
1Y
82.8%
Alnylam Pharmaceuticals
Market Cap: US$41.7b
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.
ALNY
US$311.10
7D
-1.9%
1Y
22.7%
BeOne Medicines
Market Cap: US$31.3b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$282.72
7D
-0.9%
1Y
7.7%
BridgeBio Pharma
Market Cap: US$13.6b
A biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases.
BBIO
US$70.07
7D
1.0%
1Y
101.5%
Ionis Pharmaceuticals
Market Cap: US$11.8b
A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
IONS
US$71.32
7D
-1.4%
1Y
117.9%
AbbVie
Market Cap: US$368.4b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$206.23
7D
-8.5%
1Y
-2.7%
Jazz Pharmaceuticals
Market Cap: US$11.1b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ
US$181.80
7D
0.8%
1Y
29.3%
Eli Lilly
Market Cap: US$820.1b
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY
US$917.50
7D
-6.1%
1Y
8.9%
BioMarin Pharmaceutical
Market Cap: US$10.7b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$55.03
7D
-6.8%
1Y
-23.1%
Natera
Market Cap: US$28.0b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$202.73
7D
6.5%
1Y
35.5%
Viatris
Market Cap: US$15.8b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$13.50
7D
-2.2%
1Y
43.0%
Royalty Pharma
Market Cap: US$26.4b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPRX
US$45.53
7D
-0.7%
1Y
35.9%
Exact Sciences
Market Cap: US$19.8b
Provides cancer screening and diagnostic test products in the United States and internationally.
EXAS
US$103.92
7D
0.6%
1Y
134.7%
Elanco Animal Health
Market Cap: US$12.3b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$25.12
7D
10.8%
1Y
137.4%
Waters
Market Cap: US$28.9b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$299.57
7D
5.7%
1Y
-17.5%